ArticleScientific reports2026
The effects of atherosclerotic cardiovascular disease and ten-year atherosclerotic cardiovascular disease risk score on mental health status.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherosclerotic cardiovascular disease (ASCVD) is a major cause of mortality worldwide. This study aims to investigate the relationship between the 10-year ASCVD risk score and mental disorders.This study analyzed data from 1154 participants aged 25 to 70 enrolled in the Shiraz Heart Study cohort between 2016 and 2019. The ten-year ASCVD risk score was estimated using the ASCVD risk score estimator recommended by the American College of Cardiology and American Heart Association guidelines. Mental health was evaluated using a 28-item general health questionnaire concurrently with the ASCVD risk calculation. A multiple logistic regression model was employed for multivariate analysis. The mean age of participants was 44.25 ± 8.88 years, and most were men (n = 621, 53.8%). A multiple logistic regression model demonstrated that having ASCVD is associated with increased odds of somatic symptoms (OR 1.138, 95% CI 1.069-1.212), anxiety and insomnia (OR 1.113, 95% CI 1.043-1.188), severe depression (OR 1.173, 95% CI 1.084-1.269), and total general health scores (OR 1.053, CI 1.027-1.079). Another multiple logistic regression model showed that among participants without ASCVD, 10-year ASCVD risk score ≥ 5% is associated with increased odds of somatic symptoms (OR 1.126 95%CI 1.035-1.224), anxiety and insomnia (OR 1.117, 95% CI 1.031-1.211), social dysfunction (OR 1.121, 95% CI 1.034-1.215), severe depression (OR 1.195, 95% CI 1.078-1.324), and total general health scores (OR 1.068, CI 1.035-1.102). ASCVD and a 10-year ASCVD risk score ≥ 5 are associated with the development of mental disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.